» Articles » PMID: 30817453

Interaction Between Low-density Lipoprotein-cholesterolaemia, Serum Uric Level and Incident Hypertension: Data from the Brisighella Heart Study

Overview
Journal J Hypertens
Date 2019 Mar 1
PMID 30817453
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Previous evidence suggest that high low-density lipoprotein cholesterol (LDL-C) and serum uric acid (SUA) levels are risk factors for endothelial dysfunction and vascular ageing. The aim of our study was to evaluate the short-term interaction between SUA, LDL-C and incident hypertension in a sample of overall healthy individuals.

Methods: In January 2018, we selected from the general database of the Brisighella Heart Study four groups of age and sex-matched nonhypertensive individuals with different levels of LDL-C and SUA level and examined during the 2008 population survey. Incident hypertension has been defined as the increase of SBP values over 140 mmHg and/or of DBP over 90 mmHg and or the beginning of an antihypertensive treatment.

Results: In a model adjusted for age, sex, baseline blood pressure, family history of hypertension, smoking status, BMI and physical activity intensity, hazard rations for hypertension development compared with individuals with baseline normal LDL-C and SUA levels are 1.14 [95% confidence interval (95% CI) 0.87-1.55] for individuals with isolated high LDL-C level, 1.55 (95% CI 0.96-2.48) for individuals with isolated high SUA level and 1.57 (95% CI 1.20-2.15) for individuals with both high SUA and LDL-C levels.

Conclusion: In an overall healthy population sample, the contemporary presence of suboptimal LDL-C and SUA values is associated with an increased risk to develop hypertension.

Citing Articles

Risk of Cardiovascular Events in Metabolically Healthy Overweight or Obese Adults: Role of LDL-Cholesterol in the Stratification of Risk.

Palatini P, Virdis A, Masi S, Mengozzi A, Casiglia E, Tikhonoff V Diagnostics (Basel). 2024; 14(13).

PMID: 39001205 PMC: 11240609. DOI: 10.3390/diagnostics14131314.


Association between hyperuricemia and long-term mortality in patients with hypertension: results from the NHANES 2001-2018.

Yin Y, Zhou E, Wu J Front Cardiovasc Med. 2024; 11:1306026.

PMID: 38380182 PMC: 10876877. DOI: 10.3389/fcvm.2024.1306026.


Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?.

Golubeva J, Sheptulina A, Elkina A, Liusina E, Kiselev A, Drapkina O Biomedicines. 2023; 11(9).

PMID: 37760906 PMC: 10525922. DOI: 10.3390/biomedicines11092465.


Bisdemethoxycurcumin suppresses the progression of atherosclerosis and VSMC-derived foam cell formation by promoting lipophagy.

Zuo J, Guo S, Qin X Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(12):3659-3670.

PMID: 37289282 DOI: 10.1007/s00210-023-02558-7.


Purine Metabolism Dysfunctions: Experimental Methods of Detection and Diagnostic Potential.

Cicero A, Fogacci F, Di Micoli V, Angeloni C, Giovannini M, Borghi C Int J Mol Sci. 2023; 24(8).

PMID: 37108190 PMC: 10138451. DOI: 10.3390/ijms24087027.